|Articles|January 18, 2002
What's New on the CBER Web Site 12/24/2001 through 12/28/2001
Author(s)BioPharm International Editors
Recall of reagent red blood cells (two notices) and advisory committee meetings
Advertisement
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
New Lymphoma Indication for CAR T-Cell Therapy Shapes Pipeline
2
Neurimmune and AstraZeneca Expand Efforts to Accelerate Fibril-Depleting Therapies
3
New Draft Guidance Highlights FDA Push Toward Human-Relevant Safety Models
4
Implementing Automation and Flexible Design for Allogeneic Manufacturing
5
